Spectral Medical Inc.
TSX:EDT.TOMedical - Diagnostics & Research
-$0.02 today
- Market cap
- $306.00M
- Beta
- 0.23
- P/E (TTM)
- -10.5
- EPS (TTM)
- -$0.13
Volume 0.02M
Average 0.06M
EDT.TO Free Cash Flow
Operating cash flow minus capital expenditures: cash available for debt repayment, dividends, and buybacks.
Spectral Medical Inc.TSX: EDT.TO
Free Cash Flow · Q1 FY2026 · quarter ended Mar 2026
Free cash flow growth accelerates
Q1 FY2026 free cash flow of CA$2.39M (cash outflow) rose 66.4% year over year, ahead of the +23.3% change in trailing-twelve-month free cash flow. Sequentially, it fell 28.7% from the prior quarter. Over 3 fiscal years it compounded at -0.7% a year.
Context
- Free cash flow amounted to 398.0% of revenue in FY2025, up 11.1 pp from a year earlier.
- Free cash flow grew in size in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +66.4% holds above the trailing-twelve-month pace of +23.3%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Free Cash Flow history
CAD · from the cash flow
- Latest · FY2025
- (9.72M) CAD
- Year-over-year change
- -9.9%
| Period | Period end | Free Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (9.72M) | -9.9% |
| FY2024 | 2024-12-31 | (8.85M) | +18.9% |
| FY2023 | 2023-12-31 | (10.91M) | -9.8% |
| FY2022 | 2022-12-31 | (9.93M) | -8.2% |
| FY2021 | 2021-12-31 | (9.18M) | — |
Free Cash Flow vs competitors
How EDT.TO compares with its peers on the latest reported figures
- Peers report in different currencies, so free cash flow is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +23.3% is the 6th highest of 8, against a peer median of +40.8%.
- Free cash flow amounts to 403.5% of revenue for EDT.TO, versus a peer median of 20.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | CA$77.34M CAD | -56.3% | -50.3% | 24.9% | |
PRN.TOProfound Medical Corp. | LTM Mar 2026 | $38.5M USD | +44.5% | +14.8% | 205.2% |
| LTM Mar 2026 | CA$36.06M CAD | +1163.3% | -34.4% | 11.3% | |
| LTM Mar 2026 | $32.14M USD | +26.7% | +15.8% | — | |
| LTM Mar 2026 | $29.99M USD | +40.8% | +42.3% | 58.9% | |
| LTM Mar 2026 | CA$11.14M CAD | +23.3% | -0.7% | 403.5% | |
| LTM Mar 2026 | $7.86M USD | -52.0% | -6.7% | 15.4% | |
| LTM Mar 2026 | CA$3.4M CAD | +98.2% | — | 5.1% | |
| Peer median (excluding EDT.TO) | — | +40.8% | +4.1% | 20.1% | |
Competitors are the stored peer set for EDT.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (8.79M) | (11.25M) | (15.66M) | (15.4M) | (47.69M) |
| Depreciation & Amortization | 294K | 272K | 218K | 251K | 250K |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 1.26M | 1.2M | 1.49M | 1.68M | 2.12M |
| Change in Working Capital | (1.76M) | 579K | (406K) | 1.01M | (189K) |
| Accounts Receivables | 55K | (877K) | 870K | (265K) | 246K |
| Inventory | (51K) | (47K) | (26K) | 137K | (148K) |
| Accounts Payables | (1.11M) | 1.65M | (267K) | (51K) | (265K) |
| Other Working Capital | (656K) | (142K) | (983K) | 1.19M | (22K) |
| Other Non-Cash Items | 288K | (698K) | 3.64M | 3.64M | 33.88M |
| Operating Cash Flow | (8.7M) | (9.9M) | (10.72M) | (8.82M) | (9.52M) |
| Capital Expenditures | (483K) | (33K) | (185K) | (27K) | (195K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 158K | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (325K) | (33K) | (185K) | (27K) | (195K) |
| Debt Repayment | (113K) | 3.71M | 3.93M | 9.74M | 9.67M |
| Common Stock Issued | 10M | 4.03M | 0 | 1.15M | 3.4M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 2.28M | 1.72M | 1.51M | (2.02M) | (155K) |
| Financing Cash Flow | 12.17M | 9.46M | 5.44M | 8.88M | 12.91M |
| Effect of Forex Changes | (56K) | 0 | 0 | 0 | 0 |
| Net Change in Cash | 3.08M | (476K) | (5.46M) | 36K | 1.08M |
| Free Cash Flow | (9.18M) | (9.93M) | (10.91M) | (8.85M) | (9.72M) |
Spectral Medical Inc.
TSX:EDT.TO
Intrinsic Alpha fair value
Locked
Current Price
$1.04
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.